T Knife
T-knife is a developer of T cell receptors intended for T cell therapy of cancer.The company uses a humanized TCR mice platform to carry human TCRαβ gene loci and recombine a broad repertoire of human TCRs, enabling the efficient generation and virtual selection of cell receptors for any human tumor antigen.
View Top Employees for T Knife
|
Website | t-knife.com |
|
Industry | Biotechnology |
|
Employees | 14 |
|
Founded | 2018 |
|
Funding | 197,435,084 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Website | t-knife.com |
|
|
Industry | Biotechnology |
|
|
Employees | 14 |
|
|
Founded | 2018 |
|
linkedin.com/company/t-knife | |
|
|
Funding | 197,435,084 USD |
Email Patterns for T Knife
Top Competitors for T Knife
T Knife Questions
Where are T Knife's headquarters?
T Knife's headquarters are in
What is T Knife's official website?
T Knife's website is t-knife.com
How many employees are working in T Knife right now?
T Knife has
14 employees.
View the Email and Phone Numbers for all 14 working at T Knife.
What is T Knife's industry?
T Knife's industry is
Biotechnology
Who are T Knife's top competitors?
T Knife's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are T Knife's categories?
T Knife's categories are -
When was T Knife's founded?
T Knife's founding year is 2018
What is T Knife's funding?
T Knife's funding is 197,435,084 USD
What is T Knife's current status?
T Knife's current status is operating
Top T Knife Employees
Vice President Of It
scott.newins@shiftyourtech.com
+1202-403-4441
Senior Vice President And Chief Operating Officer
megbaierlein@gmail.com
+1415-482-8800
Senior Vice President And Chief Manufacturing Officer
daatwuk@gmail.com
+1405-826-2109
Cbo And Chief Financial Officer
landis@mba.berkeley.edu
+1650-421-9520
Pre Clinical Scientist
+6142-139-4820
Chief Executive Officer
tsoloway@transcept.com
+1415-638-6556
Cell Therapy Mfg Manager
lterry@audentestx.com
+1404-512-9600
